31 results on '"Waldstreicher, Joanne"'
Search Results
2. A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC)
3. Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank.
4. Data Sharing -- A New Era for Research Funded by the U.S. Government.
5. Drugs of unproven benefit for COVID-19: a pharma perspective on ethical allocation of available therapies
6. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
7. Sustained Decrease in Incidence of Acute Urinary Retention and Surgery With Finasteride for 6 Years in Men With Benign Prostatic Hyperplasia
8. Lowering Low Density Lipoprotein Cholesterol with Simvastatin, a Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitor, Does Not Affect Luteal Function in Premenopausal Women
9. Measuring Reversal of Hair Miniaturization in Androgenetic Alopecia by Follicular Counts in Horizontal Sections of Serial Scalp Biopsies: Results of Finasteride 1 mg Treatment of Men and Postmenopausal Women
10. The Long-Term Effect Of Specific Type II 5α-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled Trial
11. Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia
12. Androgen antagonists: Potential role in prostate cancer prevention
13. Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride
14. SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
15. Technology-Enabled Clinical Trials: Transforming Medical Evidence Generation.
16. Finasteride in the treatment of men with frontal male pattern hair loss
17. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo
18. Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia
19. Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy?
20. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia
21. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia
22. Bumps and bridges on the road to responsible sharing of clinical trial data.
23. The Yale Open Data Access (YODA) Project--A Mechanism for Data Sharing.
24. Patient-Perceived Importance of Negative Effects of Androgenetic Alopecia in Women.
25. Managing Conflicts of Interest in Industry-Sponsored Clinical Research: More Physician Engagement Is Required.
26. Data Acquisition, Curation, and Use for a Continuously Learning Health System.
27. A multirater validation study to assess the reliability of acne lesion counting
28. Biologic Variability of Prostate-Specific Antigen and its Usefulness as a Marker for Prostate Cancer: Effects of Finasteride
29. Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia
30. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia
31. Storage (Irritative) and Voiding (Obstructive) Symptoms as Predictors of Benign Prostatic Hyperplasia Progression and Related Outcomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.